JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soler, C.
Right arrow Articles by Carpenter, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soler, C.
Right arrow Articles by Carpenter, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 268, Issue 29, 22010-22019, Oct, 1993

Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor

C Soler, L Beguinot, A Sorkin and G Carpenter
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146.

The importance of the carboxyl-terminal domain of the epidermal growth factor (EGF) receptor and its five autophosphorylation sites in the in vivo interaction and tyrosine phosphorylation of the ras GTPase- activating protein (rasGAP) has been investigated, using NIH 3T3 cells transfected with mutant EGF receptors. Phosphorylation of rasGAP by EGF receptor mutants, in which one to four autophosphorylation sites (Tyr- 1173, -1148, -1086, and -1068) were mutated to phenylalanine, was reduced by 50-60% compared to the wild-type receptor. Elimination of these four autophosphorylation sites by truncation of 123 carboxyl- terminal residues of the EGF receptor paralleled results obtained with point mutants. Substantial inhibition (about 90%) of rasGAP tyrosine phosphorylation by the EGF receptor occurred only when the remaining autophosphorylation site (Tyr-992) was mutated, in the context of this truncated receptor or in the full-length receptor mutated at all four other autophosphorylation sites. However, a point mutation of only Tyr- 992 in the full-length receptor suppressed tyrosine phosphorylation of rasGAP only by 50%. In contrast, an EGF receptor lacking the last 214 amino acid residues (Dc214), which encompasses all five autophosphorylation sites, phosphorylated rasGAP to the same extent as the wild-type receptor. However, this truncated receptor was significantly impaired in its capacity to phosphorylate phospholipase C- gamma 1. Interestingly, while EGF receptor autophosphorylation sites are required for EGF-induced rasGAP association with the receptor, maximal phosphorylation of rasGAP by the truncated receptor Dc214 occurred without detectable formation of receptor-rasGAP complexes. Furthermore, the capacity of mutated EGF receptors to bring about focal transformation was correlated with their capacity to phosphorylate rasGAP.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
Y.-i. Ozaki, S. Sasagawa, and S. Kuroda
Dynamic Characteristics of Transient Responses
J. Biochem., June 1, 2005; 137(6): 659 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sorkina, F. Huang, L. Beguinot, and A. Sorkin
Effect of Tyrosine Kinase Inhibitors on Clathrin-coated Pit Recruitment and Internalization of Epidermal Growth Factor Receptor
J. Biol. Chem., July 19, 2002; 277(30): 27433 - 27441.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Levkowitz, H. Waterman, E. Zamir, Z. Kam, S. Oved, W. Y. Langdon, L. Beguinot, B. Geiger, and Y. Yarden
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Genes & Dev., December 1, 1998; 12(23): 3663 - 3674.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Miloso, M. Mazzotti, W. C. Vass, and L. Beguinot
SHC and GRB-2 Are Constitutively Activated by an Epidermal Growth Factor Receptor with a Point Mutation in the Transmembrane Domain
J. Biol. Chem., August 18, 1995; 270(33): 19557 - 19562.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. V. Alvarez, K.-J. Shon, M. Miloso, and L. Beguinot
Structural Requirements of the Epidermal Growth Factor Receptor for Tyrosine Phosphorylation of eps8 and eps15, Substrates Lacking Src SH2 Homology Domains
J. Biol. Chem., July 7, 1995; 270(27): 16271 - 16276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Eriksson, E. Nånberg, L. Rönnstrand, U. Engström, U. Hellman, E. Rupp, G. Carpenter, C.-H. Heldin, and L. Claesson-Welsh
Demonstration of Functionally Different Interactions between Phospholipase C-[IMAGE] and the Two Types of Platelet-derived Growth Factor Receptors
J. Biol. Chem., March 31, 1995; 270(13): 7773 - 7781.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1993 by the American Society for Biochemistry and Molecular Biology.